Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises OLP Q1 2026 Earnings EPS Surpasses Estimates as Management Highlights Portfolio Performance PSO Q4 2025 Earnings Modest EPS Beat Highlights Steady Execution Deutsche Bank DB Q1 2026 Earnings EPS Slightly Beats Estimates Amid Mixed Market Reaction ROIV Q1 2026 Earnings Missed Estimates as Pipeline Progress Takes Center Stage Tactile Systems Technology TCMD Shows Modest Gains Amidst Narrow Trading Range Entrada Therapeutics TRDA Edges Lower Amid Light Trading Key Support at 617 in Focus CEE Sees Modest Uptick as Central and Eastern Europe Fund Gains 075 Nuveen Select Tax Free Income Portfolio NXP Holds Near Resistance Amid Modest Gains Nike NKE Q1 2026 Earnings EPS Surges Past Estimates with 2289 Beat